000 | 01247 a2200373 4500 | ||
---|---|---|---|
005 | 20250512020445.0 | ||
264 | 0 | _c19890803 | |
008 | 198908s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeiner, L M | |
245 | 0 | 0 |
_aPhase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. _h[electronic resource] |
260 |
_bCancer research _cJul 1989 |
||
300 |
_a4062-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotoxins _xadverse effects |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
650 | 0 | 4 |
_aRicin _xadverse effects |
700 | 1 | _aO'Dwyer, J | |
700 | 1 | _aKitson, J | |
700 | 1 | _aComis, R L | |
700 | 1 | _aFrankel, A E | |
700 | 1 | _aBauer, R J | |
700 | 1 | _aKonrad, M S | |
700 | 1 | _aGroves, E S | |
773 | 0 |
_tCancer research _gvol. 49 _gno. 14 _gp. 4062-7 |
|
999 |
_c2792617 _d2792617 |